Property, Plant, and Equipment: The sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
Ligand Pharmaceuticals Incorporated (LGND) had Property, Plant, and Equipment of $3.47M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$115.46M |
|
$117.27M |
|
$3.80M |
|
$111.66M |
|
$60.53M |
|
$54.93M |
|
$86.21M |
|
$141.14M |
|
$133.34M |
|
$117.27M |
|
$117.27M |
|
$117.27M |
|
$108.16M |
|
$54.93M |
|
$62.31M |
|
19.58M |
|
20.63M |
|
$5.99 |
|
$5.68 |
|
| Balance Sheet Financials | |
$753.92M |
|
|
Property, Plant, and Equipment |
$3.47M |
$722.85M |
|
$1.48B |
|
$30.54M |
|
$445.49M |
|
$496.06M |
|
$526.60M |
|
$950.17M |
|
$615.10M |
|
$950.17M |
|
19.66M |
|
| Cash Flow Statement Financials | |
$3.44M |
|
$-359.22M |
|
$419.89M |
|
$72.31M |
|
$139.38M |
|
$67.07M |
|
$32.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.69 |
|
-- |
|
-- |
|
0.32 |
|
0.47 |
|
96.71% |
|
47.58% |
|
47.58% |
|
-- |
|
122.24% |
|
101.57% |
|
$2.19M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.32 |
|
1.99 |
|
45.28 |
|
12.34% |
|
19.07% |
|
7.94% |
|
8.40% |
|
$48.34 |
|
$0.11 |
|
$0.17 |
|